- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Telix Pharmaceuticals Ltd ADR (TLX)
Telix Pharmaceuticals Ltd ADR stock price live, this page displays NASDAQ TLX stock exchange data. View the TLX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Telix Pharmaceuticals Ltd ADR real time stock price chart below.
What Is the Telix Pharmaceuticals Ltd ADR Stock Price Today?
The Telix Pharmaceuticals Ltd ADR stock price today is 15.97.
What Is the Stock Symbol for Telix Pharmaceuticals Ltd ADR?
The stock symbol for Telix Pharmaceuticals Ltd ADR is "TLX."
What Stock Exchange Does Telix Pharmaceuticals Ltd ADR Trade On?
Telix Pharmaceuticals Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Telix Pharmaceuticals Ltd ADR a Good Stock to Buy?
Determining whether Telix Pharmaceuticals Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLX quote. (ISIN: US87961M1053)
What Is the Telix Pharmaceuticals Ltd ADR Stock Price Today?
The Telix Pharmaceuticals Ltd ADR stock price today is 15.97.
What Is the Stock Symbol for Telix Pharmaceuticals Ltd ADR?
The stock symbol for Telix Pharmaceuticals Ltd ADR is "TLX."
What Stock Exchange Does Telix Pharmaceuticals Ltd ADR Trade On?
Telix Pharmaceuticals Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Telix Pharmaceuticals Ltd ADR a Good Stock to Buy?
Determining whether Telix Pharmaceuticals Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLX quote. (ISIN: US87961M1053)
NASDAQ
Currency in USD
15.97
-0.13(-0.81%)
Closed·
After Hours
15.71-0.26(-1.63%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.65
16.00
52 wk Range
13.61
30.36
TLX Scorecard
Full Analysis
Net income is expected to grow this year
TLX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.6516.00
52 wk Range
13.6130.36
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TLX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
23.01
Upside
+44.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Telix Pharmaceuticals Ltd ADR Company Profile
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases. The company operates through three segments: Therapeutics, Precision Medicine, and Telix Manufacturing Solutions. It offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. The company’s products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX007-CDx, a cold kit for the preparation of imaging for prostate cancer; TLX66-CDx to treat bone marrow conditioning. It also TLX250 for the treatment of clear cell renal cell carcinoma; TLX101 for the treatment of glioblastoma (brain cancer); TLX66 for the treatment of bone marrow conditioning. In addition, the company develops TLX300 for the treatment of soft tissue sarcoma; TLX592, a prostate cancer therapy candidate for targeted alpha therapy; and TLX090, a bone-seeking agent for bone metastases and pain palliation. Further, it operates in Australia, New Zealand, Belgium, Japan, Switzerland, Germany, the United Kingdom, Canada, Singapore, Austria, Spain, France, and the United States. Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia.
Compare TLX to Peers and Sector
Metrics to compare | TLX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTLXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 163.3x | −3.8x | −0.5x | |
PEG Ratio | 0.20 | −0.02 | 0.00 | |
Price/Book | 14.3x | 2.6x | 2.6x | |
Price / LTM Sales | 10.4x | 13.6x | 3.2x | |
Upside (Analyst Target) | 44.1% | 327.5% | 45.4% | |
Fair Value Upside | Unlock | 11.4% | 6.9% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23.01
(+44.10% Upside)
Earnings
Latest Release
Apr 22, 2025
EPS / Forecast
0.0921 / --
Revenue / Forecast
186.00M / --
People Also Watch
FAQ
What Is the Telix Pharmaceuticals ADR (TLX) Stock Price Today?
The Telix Pharmaceuticals ADR stock price today is 15.97
What Stock Exchange Does Telix Pharmaceuticals ADR Trade On?
Telix Pharmaceuticals ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Telix Pharmaceuticals ADR?
The stock symbol for Telix Pharmaceuticals ADR is "TLX."
What Is the Telix Pharmaceuticals ADR Market Cap?
As of today, Telix Pharmaceuticals ADR market cap is 5.36B.
What Is Telix Pharmaceuticals ADR's Earnings Per Share (TTM)?
The Telix Pharmaceuticals ADR EPS (TTM) is 0.15.
When Is the Next Telix Pharmaceuticals ADR Earnings Date?
Telix Pharmaceuticals ADR will release its next earnings report on 20 Aug 2025.
From a Technical Analysis Perspective, Is TLX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Telix Pharmaceuticals ADR Stock Split?
Telix Pharmaceuticals ADR has split 0 times.
How Many Employees Does Telix Pharmaceuticals ADR Have?
Telix Pharmaceuticals ADR has 423 employees.
What is the current trading status of Telix Pharmaceuticals ADR (TLX)?
As of 12 July 2025, Telix Pharmaceuticals ADR (TLX) is trading at a price of 15.97, with a previous close of 16.10. The stock has fluctuated within a day range of 15.65 to 16.00, while its 52-week range spans from 13.61 to 30.36.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.